Research Unit Molecular Bases of Human Diseases, Sfax College of Medicine, Tunisia.
Arch Med Res. 2011 Jul;42(5):398-404. doi: 10.1016/j.arcmed.2011.08.006. Epub 2011 Aug 18.
In this study we investigated the carotid intima-media thickness (cIMT) in Tunisian patients with Behçet's disease (BD), and we evaluated the relationship between traditional and nontraditional cardiovascular risk factors, disease manifestations, disease severity, use of immunosuppressive agents and cIMT in patients with BD.
Fifty patients with BD were individually matched to 50 control subjects on the basis of age, gender and traditional cardiovascular risk factors. Subjects with diabetes mellitus, evidence of myocardial infarction or cerebrovascular disease were excluded from the study. Patients with arterial involvement were also excluded. We measured serum high-sensitivity C-reactive protein (hsCRP), fibrinogen, creatinine levels and lipid profile. We also measured serum vitamin B12, folate, total plasma homocysteine levels, and HOMA-IR values. We used B-mode ultrasonography to assess the cIMT.
cIMT in the BD group was significantly higher than in the control group (0.658 ± 0.112 mm vs. 0.581 ± 0.087 mm, respectively, p <10(-3)). The frequency of plaques in the carotid arteries was similar between study groups. In univariate analyses, the cIMT of BD patients was correlated with age (r = 0.510, p <10(-3)), male gender (p = 0.032), and creatinine clearance (r = -0.421, p = 0.003). It was inversely correlated with HOMA-IR values and serum vitamin B12 level. cIMT values were independent of disease manifestations, disease duration, or corticoid therapy. In the multivariate analysis, only male gender and creatinine clearance remained significantly associated with cIMT.
Our data indicate morphologic evidence of subclinical atherosclerosis in patients with BD. Increased arterial wall thickness was not associated with the disease duration, clinical manifestations and immunosuppressive therapy.
本研究旨在探讨突尼斯贝切特病(BD)患者的颈动脉内膜中层厚度(cIMT),评估传统和非传统心血管危险因素、疾病表现、疾病严重程度、免疫抑制剂的使用与 BD 患者 cIMT 之间的关系。
在这项研究中,我们对 50 名 BD 患者进行了个体匹配,匹配的因素包括年龄、性别和传统心血管危险因素,然后与 50 名对照受试者进行了匹配。排除了患有糖尿病、心肌梗死或脑血管疾病的患者。排除了有动脉受累的患者。我们测量了血清高敏 C 反应蛋白(hsCRP)、纤维蛋白原、肌酐水平和血脂谱。我们还测量了血清维生素 B12、叶酸、总血浆同型半胱氨酸水平和 HOMA-IR 值。我们使用 B 型超声评估 cIMT。
BD 组的 cIMT 明显高于对照组(分别为 0.658 ± 0.112 mm 和 0.581 ± 0.087 mm,p <10(-3))。颈动脉斑块的发生率在两组间相似。在单因素分析中,BD 患者的 cIMT 与年龄(r = 0.510,p <10(-3))、男性(p = 0.032)和肌酐清除率(r = -0.421,p = 0.003)相关。它与 HOMA-IR 值和血清维生素 B12 水平呈负相关。cIMT 值与疾病表现、疾病持续时间或皮质激素治疗无关。在多因素分析中,只有性别和肌酐清除率与 cIMT 显著相关。
我们的数据表明,BD 患者存在亚临床动脉粥样硬化的形态学证据。动脉壁增厚与疾病持续时间、临床表现和免疫抑制剂治疗无关。